These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19236217)

  • 21. Safety of ultrasound contrast agents in patients with known or suspected cardiac shunts.
    Parker JM; Weller MW; Feinstein LM; Adams RJ; Main ML; Grayburn PA; Cosgrove DO; Goldberg BA; Darge K; Nihoyannopoulos P; Wilson S; Monaghan M; Piscaglia F; Fowlkes B; Mathias W; Moriyasu F; Chammas MC; Greenbaum L; Feinstein SB
    Am J Cardiol; 2013 Oct; 112(7):1039-45. PubMed ID: 23816393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does contrast echocardiography with Optison induce myocardial necrosis in humans?
    Borges AC; Walde T; Reibis RK; Grohmann A; Ziebig R; Rutsch W; Schimke I; Baumann G
    J Am Soc Echocardiogr; 2002 Oct; 15(10 Pt 1):1080-6. PubMed ID: 12373250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience.
    Dolan MS; Gala SS; Dodla S; Abdelmoneim SS; Xie F; Cloutier D; Bierig M; Mulvagh SL; Porter TR; Labovitz AJ
    J Am Coll Cardiol; 2009 Jan; 53(1):32-8. PubMed ID: 19118722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images.
    Kitzman DW; Goldman ME; Gillam LD; Cohen JL; Aurigemma GP; Gottdiener JS
    Am J Cardiol; 2000 Sep; 86(6):669-74. PubMed ID: 10980221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac imaging using Optison.
    Clark LN; Dittrich HC
    Am J Cardiol; 2000 Aug; 86(4A):14G-18G. PubMed ID: 10997346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial.
    Cohen JL; Cheirif J; Segar DS; Gillam LD; Gottdiener JS; Hausnerova E; Bruns DE
    J Am Coll Cardiol; 1998 Sep; 32(3):746-52. PubMed ID: 9741522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of contrast agent use during stress echocardiography: a 4-year experience from a single-center cohort study of 26,774 patients.
    Abdelmoneim SS; Bernier M; Scott CG; Dhoble A; Ness SA; Hagen ME; Moir S; McCully RB; Pellikka PA; Mulvagh SL
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1048-56. PubMed ID: 19761981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast-enhanced diagnostic ultrasound causes renal tissue damage in a porcine model.
    Miller DL; Dou C; Wiggins RC
    J Ultrasound Med; 2010 Oct; 29(10):1391-401. PubMed ID: 20876892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of the safety and clinical utility of contrast echocardiography.
    Chai SC; Tan PJ; Tong KL
    Singapore Med J; 2020 Apr; 61(4):181-183. PubMed ID: 31820006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The safety profile of perflutren microsphere contrast echocardiography during rest and stress imaging: results from an Australian multicentre cohort.
    Platts DG; Luis SA; Roper D; Burstow D; Call T; Forshaw A; Pascoe R
    Heart Lung Circ; 2013 Dec; 22(12):996-1002. PubMed ID: 23764145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of ultrasound contrast agents in current clinical practice with special focus on DEFINITY
    Salih M; Ali SM; Jena N; Ananthasubramaniam K
    Future Cardiol; 2021 Mar; 17(2):197-214. PubMed ID: 32897099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicare Prescription Drug Plan Formulary Restrictions After Postmarket FDA Black Box Warnings.
    Solotke MT; Ross JS; Shah ND; Karaca-Mandic P; Dhruva SS
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1201-1217. PubMed ID: 31663461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the hemolytic potential of Optison and Albunex in whole human blood in vitro: acoustic pressure, ultrasound frequency, donor and passive cavitation detection considerations.
    Miller MW; Everbach EC; Cox C; Knapp RR; Brayman AA; Sherman TA
    Ultrasound Med Biol; 2001 May; 27(5):709-21. PubMed ID: 11397535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does contrast echocardiography induce increases in markers of myocardial necrosis, inflammation and oxidative stress suggesting myocardial injury?
    Knebel F; Schimke I; Eddicks S; Walde T; Ziebig R; Schattke S; Baumann G; Borges AC
    Cardiovasc Ultrasound; 2005 Aug; 3():21. PubMed ID: 16107209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic ultrasound-induced membrane damage in phagocytic cells loaded with contrast agent and its relation to Doppler-mode images.
    Miller DL; Quddus J
    IEEE Trans Ultrason Ferroelectr Freq Control; 2002 Aug; 49(8):1094-102. PubMed ID: 12201456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaphylactoid response to Optison(R) and its effects on pulmonary function in two dogs.
    Yamaya Y; Niizeki K; Kim J; Entin P; Wagner H; Wagner PD
    J Vet Med Sci; 2004 Nov; 66(11):1429-32. PubMed ID: 15585961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of contrast ultrasonography with perflutren lipid microspheres on microvessel injury.
    Kobayashi N; Yasu T; Yamada S; Kudo N; Kuroki M; Miyatake K; Kawakami M; Saito M
    Circ J; 2003 Jul; 67(7):630-6. PubMed ID: 12845189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast echocardiography: safety in numbers.
    Main ML
    Cardiology; 2012; 122(4):248-50. PubMed ID: 22906912
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro, animal, and human characterization of OPTISON infusions for myocardial contrast echocardiography.
    Miller JJ; Tiemann K; Podell S; Doerr Stevens JK; Kuvelas T; Greener Y; Killam AL; Goenechea J; Dittrich HC; Becher H
    J Am Soc Echocardiogr; 1999 Dec; 12(12):1027-34. PubMed ID: 10588777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of ultrasound contrast agents in stress echocardiography.
    Gabriel RS; Smyth YM; Menon V; Klein AL; Grimm RA; Thomas JD; Sabik EM
    Am J Cardiol; 2008 Nov; 102(9):1269-72. PubMed ID: 18940305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.